*.*.44.201
药智数据企业版
量身打造,体验升级
立即前往
VIP免费试用申请
登录 注册
反馈纠错 帮助中心
药智数据企业版注册数据库:增设了"联合申报"、"临床试验默认许可日期"等搜索条件,让搜索页面纬度更加全面,还有热点搜索和高级条件组合检索等检索功能 等你来体验!
-
你目前无法使用部分二次筛选功能 请联系客服开通更多权限和功能!
药品名称 批准类型 活性成分 适应症 上市发布公告 临床试验快照 批准日期 申请机构
Alhemo Biologics concizumab-mtci For routine prophylaxis to prevent bleeding episodes in hemophilia A and B 2024-12-20 NOVO NORDISK INC
Alyftrek NME vanzacaftor, tezacaftor, and deutivacaftor To treat cystic fibrosis 2024-12-20 VERTEX PHARMS INC
Tryngolza NME olezarsen To treat familial chylomicronemia syndrome 2024-12-19 IONIS PHARMS INC
Ensacove NME ensartinib To treat non-small cell lung cancer 2024-12-18 XCOVERY
Crenessity NME crinecerfont To treat classic congenital adrenal hyperplasia Press Release 2024-12-13 NEUROCRINE
Unloxcyt NME cosibelimab-ipdl To treat cutaneous squamous cell carcinoma 2024-12-13 CHECKPOINT THERAPEUTICS INC
Bizengri Biologics zenocutuzumab-zbco To treat non-small cell lung cancer and pancreatic adenocarcinoma 2024-12-04 MERUS N.V.
Iomervu NME iomeprol For use as a radiographic contrast agent 2024-11-27 BRACCO
Rapiblyk NME landiolol To treat supraventricular tachycardia 2024-11-22 AOP ORPHAN
Attruby NME acoramidis To treat cardiomyopathy of wild-type or variant transthyretin-mediated amyloidosis 2024-11-22 BRIDGEBIO PHARMA
Ziihera Biologics zanidatamab-hrii To treat unresectable or metastatic HER2-positive (IHC 3+) biliary tract cancer 2024-11-20 JAZZ PHARMS
Revuforj NME revumenib To treat relapsed or refractory acute leukemia 2024-11-15 SYNDAX
Orlynvah NME sulopenem etzadroxil, probenecid To treat uncomplicated urinary tract infections (uUTI) 2024-10-25 ITERUM THERAPEUTICS US LTD
Vyloy Biologics zolbetuximab-clzb To treat gastric or gastroesophageal junction adenocarcinoma 2024-10-18 ASTELLAS
Hympavzi Biologics marstacimab-hncq To prevent or reduce bleeding episodes related to hemophilia A or B Press Release 2024-10-11 PFIZER INC
ITOVEBI NME inavolisib To treat locally advanced or metastatic breast cancer 2024-10-10 GENENTECH INC
Flyrcado NME flurpiridaz F 18 A radioactive diagnostic drug to evaluate for myocardial ischemia and infarction 2024-09-27 GE HLTHCARE
Cobenfy NME xanomeline and trospium chloride To treat schizophrenia Press Release 2024-09-26 BRISTOL-MYERS
Aqneursa NME levacetylleucine To treat Niemann-Pick disease type C Press Release 2024-09-24 INTRABIO
Miplyffa NME arimoclomol To treat Niemann-Pick disease type C Press Release 2024-09-20 ZEVRA DENMARK